| View |
|
DRP-9861-01
|
Ascorbic Acid + Zinc
|
New Improved Life C Plus
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/ Mineral
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
11 June 2024
|
05 February 2026
|
| View |
|
DRP-9903-01
|
Celecoxib
|
None
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
12 June 2024
|
26 May 2025
|
| View |
|
HRP-556-01
|
Methyl Salicylate
|
None
|
100 g (100%) per 100 mL
|
Solution
|
Counterirritant
|
Dann's Aid Laboratories, Inc
|
|
CLIDP Conversion
|
12 June 2024
|
18 February 2029
|
| View |
|
DRP-10091-10
|
Norepinephrine (as bitartrate)
|
Norephstar
|
1 mg/ mL (4 mg/ 4 mL)
|
Solution for I.V. Injection
|
Adrenergic and Dopaminergic Agent
|
Aju Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
04 January 2024
|
21 October 2025
|
| View |
|
DRP-13497-01
|
Amikacin (as sulfate)
|
Gokacin-100
|
50 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
07 July 2023
|
28 February 2028
|
| View |
|
DRP-13497-02
|
Amikacin (as sulfate)
|
Amikacent-100
|
50 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
03 July 2023
|
28 February 2028
|
| View |
|
DRP-13498-01
|
Amikacin (as sulfate)
|
Gokacin-250
|
125 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
03 July 2023
|
28 February 2028
|
| View |
|
DRP-13498-02
|
Amikacin (as sulfate)
|
Amikacent-250
|
125 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
03 July 2024
|
28 February 2028
|
| View |
|
DRP-13499-01
|
Amikacin (as sulfate)
|
Gokacin-500
|
250 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
07 July 2023
|
28 February 2028
|
| View |
|
DRP-13499-02
|
Amikacin (as sulfate)
|
Amikacent-500
|
250 mg/mL
|
Solution for injection (I.M./I.V.)
|
Antibacterial (Aminoglycoside)
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
12 July 2023
|
28 February 2028
|
| View |
|
DRP-8896-01
|
Epinephrine
|
Adline
|
1 mg/mL
|
Solution for Injection (IM/SC/IV Infusion)
|
Adrenergic (Alpha and Beta-Adrenoreceptor agonist)
|
PT Phapros TBK
|
Indonesia
|
CLIDP Conversion
|
22 November 2023
|
09 June 2025
|
| View |
|
DRP-6920
|
Hydrocortisone (As Sodium Succinate)
|
Cortiright 500
|
500 mg
|
Lyophilized Powder for Injection (IV/IM)
|
Corticosteroid
|
Gufic Biosciences Ltd.
|
India
|
Automatic Renewal
|
25 June 2021
|
16 November 2026
|
| View |
|
DRP-9820
|
Aluminum Hydroxide + Magnesium Hydroxide + Simethicone
|
None
|
178 mg / 233 mg / 30 mg
|
Chewable Tablet
|
Antacid/ Antiflatulent
|
Phil. United Pharma Corp.
|
Philippines
|
Initial (OTC) [PCPR)
|
15 June 2021
|
15 June 2026
|
| View |
|
DRP-6136-03
|
Ampicillin (as Sodium)
|
AMPITEK-1
|
1g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
NORTH CHINA PHARMACEUTICAL CO., LTD.
|
China
|
CLIDP Conversion
|
23 January 2024
|
13 March 2029
|
| View |
|
DRP-2513-03
|
Bisoprolol fumarate
|
Bistapro
|
10 mg
|
Film-Coated Tablet
|
Beta-Adrenoreceptor Blockers
|
LEK S.A.
|
Poland
|
CLIDP Conversion
|
01 June 2023
|
17 April 2027
|
| View |
|
DRP-2514-03
|
Bisoprolol fumarate
|
Bistapro
|
5 mg
|
Film-Coated Tablet
|
Beta-Adrenoceptor Blocker
|
Lek S.A.
|
Poland
|
CLIDP Conversion
|
11 June 2023
|
17 April 2027
|
| View |
|
DRP-6491-3
|
Rosuvastatin (as Calcium)
|
Rostad
|
10 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Lek Pharmaceuticals D.D.
|
Slovenia
|
CLIDP Conversion
|
31 May 2023
|
12 January 2026
|
| View |
|
DRP-6489-04
|
Rosuvastatin (as Calcium)
|
Rostad
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Lek Pharmaceuticals D.D
|
Slovenia
|
CLIDP Conversion
|
24 May 2023
|
12 January 2026
|
| View |
|
BRP-136-01
|
Heparin (as sodium)
|
Hemolate
|
1000 I.U./ml (5000 I.U./5ml)
|
Solution for Injection (I.V./S.C.)
|
Antithrombotic Agents
|
Troikaa Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
30 June 2024
|
10 May 2029
|
| View |
|
DR-XY29842
|
Cefalexin (as monohydrate)
|
Cepham
|
100 mg/mL
|
Powder for Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
New Myrex Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
24 June 2024
|
09 August 2029
|